New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)
Direct intratumoral injection of SD-101 with local radiation is safe in patients with relapsed or refractory lymphoma after allogeneic hematopoietic cell transplant.
Principal Investigator
Stanford Investigator(s)
- Samuel Strober
- Edgar Engleman
- Richard Hoppe
- Ronald Levy, MD
- Lauren Maeda